Gland Pharma Limited
₹1,774
INR+70.60(+4.14%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹27054.75 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹25298.96 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
37.42
Forward P/E
Price to Earnings ratio based on forecasted earnings
21.56
PEG Ratio
Price/Earnings to Growth ratio
21.56
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
4.62
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
59.75%
Operating Margin
Operating income as a percentage of revenue
12.30%
Return on Equity
Net income as a percentage of shareholders' equity
8.85%
Revenue (TTM)
Total revenue over trailing 12 months
₹5857.74 Cr+16%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1487.63 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹43.89-25.900000000000002%
Balance Sheet
Total Cash
Total cash and short-term investments
₹1839.43 Cr
Total Debt
Total short-term and long-term debt
₹372.17 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
4.27%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1486.65 - ₹2220.95
Beta
Measure of stock's volatility compared to the market
0.30
Shares Outstanding
Total number of shares issued by the company
₹16.48 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
4.85%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
1.23%
Payout Ratio
Percentage of earnings paid as dividends
0.00%